G95S (p.Gly95Ser) variant of KRT3 (Keratin, type II cytoskeletal 3)

G95S (p.Gly95Ser) in KRT3 (Keratin, type II cytoskeletal 3) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of not specified. The available variant effect predictions contribute to a CATVariant prioritization score of 0.14 / 1. The record also includes population frequency data and structural context.

G95S (p.Gly95Ser) variant details